Gog0238- A Randomized Trial Of Pelvic Irradiation With Or Without Concurrent Weekly Cisplatin In Patients With Pelvic-Only Recurrence Of Carcinoma Of The Uterine Corpus
Posted Date: May 15, 2019
- Investigator: Thomas Herzog
- Specialties: Cancer, Oncology
- Type of Study: Drug
The main purpose of this study is to compare radiation therapy in combination with weekly treatment with the chemotherapy drug cisplatin to the standard treatment for this type of cancer to see which is better. The standard treatment for patients with your type of cancer is radiation therapy alone.
Criteria:
To Be Eligible: Patient Must Be 18 Years Of Age Or Older, Patient Must Have Had A Complete Hysterectomy And Bilateral Salpingo-Oophorectomy, Patients Must Have Estimated Survival Greater Than 3 Months, No Previous Irradiation Or Severe Infection, No History Of Other Invasive Malignancies
Keywords:
Uterine Cancer, Recurrent, Uterine Cancer
For More Information:
Uc Cancer Center
513-584-7698
cancer@uchealth.com